VITZROCELL Co.Ltd (082920) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of VITZROCELL Co.Ltd stock KRW 22,268, price KRW 20,500, upside +8.6%, quality 55 out of 100. Rating: fairly valued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.
How to read this chart
60‑month range 4,789 KRW – 64,100 KRW · fair‑value band 14,768 KRW – 36,320 KRW · the 20,500 KRW price screens below the 22,268 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 6, 2026.
Follow VITZROCELL Co.Ltd in your weekly email
Every Wednesday you see whether VITZROCELL Co.Ltd is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
VITZROCELL Co.,Ltd. engages in the production and sale of lithium batteries in South Korea and the United States. The company was formerly known as Teckraf Co., Ltd. and changed its name to VITZROCELL Co., Ltd. in June 2002.
Show moreShow less
VITZROCELL Co.,Ltd. was founded in 1987 and is headquartered in Dangjin, South Korea.
Stock analysis
VITZROCELL Co.Ltd (082920) currently trades at 20,500 KRW, while our model-based Fair Value estimate is 22,268 KRW, so the stock looks roughly fairly valued today (gap 7.9%).
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 43,055 KRW per share, and 16 of the 26 models we run sit above the 20,500 KRW price.
Bear case: the Dividend Discount group reads lowest at 3,058 KRW, and 10 of the 26 models stay below the price. Data coverage for this calculation is medium.
Scenario range: 14,768 KRW (bear) to 36,320 KRW (bull), the price of 20,500 KRW sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 55/100 (solid quality), in the Industrials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
VITZROCELL Co.Ltd reported revenue of 243B KRW in FY2025 versus 113B KRW in FY2021, a compound +21.0%/yr. Reported net income was 56.9B KRW in FY2025, compounding +35.2%/yr from FY2021.
Key figures
Market cap 1.1T KRW (≈ $784M) Small · P/S ratio 9.02 · Dividend yield 1.2% · Net margin 19.8% · Return on equity 1,997% · Return on assets (EBIT) 14.0% (5-year average) · Operating margin 16.3% · Revenue (TTM) 119B KRW.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 71 out of 100 (low confidence).
What moves the price
The share trades about 68% below its 52-week high and 63% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Industrials peers we cover trades at −32% fair-value upside, at 9%, 082920 screens cheaper than that median.
Fair Value models
Bear14,768 KRWFair Value 22,268 KRWBull36,320 KRW
Price 20,500 KRW · Upside +8.6%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF16,299 KRW23,500 KRW44,996 KRW76
Growth DCF15,302 KRW24,972 KRW42,729 KRW75
Residual Income7,291 KRW9,740 KRW15,486 KRW73
All 26 models by family
DCF Models
FCF DCF16,299 KRW23,500 KRW44,996 KRW76
Owner Earnings14,741 KRW29,899 KRW57,942 KRW71
5Y Revenue Exit10,654 KRW16,670 KRW29,150 KRW69
5Y EBITDA Exit17,804 KRW31,110 KRW57,198 KRW71
5Y P/E Exit19,364 KRW42,722 KRW74,563 KRW66
10Y Revenue Exit12,360 KRW23,154 KRW29,050 KRW66
10Y EBITDA Exit17,374 KRW37,157 KRW71,414 KRW63
10Y P/E Exit18,411 KRW40,212 KRW76,000 KRW59
Earnings-Based
Graham-Dodd8,615 KRW60,076 KRW84,308 KRW60
Lynch FV23,934 KRW34,192 KRW44,450 KRW58
PEG = 1.023,934 KRW34,192 KRW44,450 KRW55
EPV11,587 KRW13,085 KRW14,331 KRW72
Dividend Discount
Gordon GGM1,779 KRW3,194 KRW4,384 KRW65
DDM Multi-Stage1,779 KRW2,923 KRW3,413 KRW65
Multiples
P/E Multiple19,953 KRW26,604 KRW33,255 KRW61
P/S Multiple8,115 KRW10,819 KRW13,524 KRW56
P/B Multiple23,245 KRW30,993 KRW38,741 KRW53
EV/EBIT19,646 KRW26,198 KRW32,749 KRW65
EV/EBITDA17,679 KRW23,575 KRW29,470 KRW66
EV/Revenue6,808 KRW9,729 KRW12,650 KRW52
Asset-Based
NCAV (Graham)3,112 KRW4,715 KRW5,894 KRW53
Growth DCF
Growth DCF15,302 KRW24,972 KRW42,729 KRW75
Rev-Margin DCF10,878 KRW19,003 KRW34,541 KRW69
Economic Profit
Residual Income7,291 KRW9,740 KRW15,486 KRW73
ROIC Compounder14,308 KRW20,306 KRW23,959 KRW71
Growth Earnings
Growth-Adj P/E30,139 KRW43,055 KRW55,972 KRW66
The fair value above starts from this blend and is adjusted for dilution from new shares.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.92/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+15.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+19.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+16.5%
Start year 2020 (pandemic). Over 10 years: +10.3% a year
Revenue growth 13 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.2%
’12
’13
’15
’16
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+10.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year+9.7%
Dividend (yield on the price)1.2%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.9.7% vs 3.2%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.16% → 29%
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far and less than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+8.6%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+16.4%
Yearly sales growth analysts expect, extended to five years.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about +6.4% a year for the price and +14.0% for the forecasts.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "VITZROCELL Co.Ltd Fair Value". https://www.fairvalue-calculator.com/stock/082920
Frequently asked questions
Is VITZROCELL Co.Ltd (082920) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of 22,268 KRW versus a price of 20,500 KRW, about +9% upside (fairly valued).
What is the fair value of 082920?
Our model-based fair value for VITZROCELL Co.Ltd is 22,268 KRW (as of Nov 6, 2026), built from audited fundamentals. The current price: 20,500 KRW.
What is the quality score of 082920?
VITZROCELL Co.Ltd has a Quality Score of 55/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for VITZROCELL Co.Ltd (082920)?
Our model-based price target is the fair value of 22,268 KRW (as of Nov 6, 2026) from 26 valuation models. Cautious scenario 14,768 KRW, optimistic scenario 36,320 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the VITZROCELL Co.Ltd stock forecast for 2026?
Our models put fair value at 22,268 KRW, about +9% upside versus a price of 20,500 KRW (fairly valued). Cautious scenario 14,768 KRW, optimistic scenario 36,320 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of VITZROCELL Co.Ltd (082920)?
VITZROCELL Co.Ltd reported trailing-twelve-month revenue of about 119B KRW (latest available figure, as of Nov 6, 2026).
Does VITZROCELL Co.Ltd pay a dividend?
VITZROCELL Co.Ltd currently shows a dividend yield of 1.15% relative to its recent price (as of Nov 6, 2026).
How much is the dividend of VITZROCELL Co.Ltd (082920)?
VITZROCELL Co.Ltd has a dividend yield of 1.2%. A dividend has been paid every year since 2019. Our assessment: Safety not assessed. Payout ratio and cash coverage are not available, so we do not judge how safe this dividend is.
What growth is priced into VITZROCELL Co.Ltd (082920)?
For today's price to be fair in a discounted-cash-flow model, VITZROCELL Co.Ltd would have to grow free cash flow by +8.6 % per year for five years (discount rate 11.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +16.5 % per year. As of Nov 6, 2026.
What discount rate (WACC) does the fair value of 082920 use?
Our models discount VITZROCELL Co.Ltd at 11.1 %: a base by market capitalisation (small), damped by beta 0.80, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For VITZROCELL Co.Ltd that is +8.6 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (11.1 %) and the same formula as our fair value.
How much growth has VITZROCELL Co.Ltd (082920) delivered so far?
Over the past 5 years revenue at VITZROCELL Co.Ltd grew +16.5 % a year. The price currently implies free-cash-flow growth of +8.6 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of VITZROCELL Co.Ltd (082920) growing?
The median revenue growth in the sector is +7.8 % a year. That is the yardstick for the growth priced into VITZROCELL Co.Ltd (+8.6 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of VITZROCELL Co.Ltd (082920)?
The free-cash-flow yield on the price is 5.66 %: that much free cash flow VITZROCELL Co.Ltd produces per unit of market value. When it exceeds the discount rate of our models (11.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of VITZROCELL Co.Ltd (082920)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For VITZROCELL Co.Ltd it is 22,268 KRW per share (as of Nov 6, 2026), against a price of 20,500 KRW. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is VITZROCELL Co.Ltd stock overvalued or undervalued in 2026?
As of Nov 6, 2026, 082920 trades below its calculated fair value: price 20,500 KRW, fair value 22,268 KRW, a gap of about +9% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 082920?
No. The price is what the market pays today (20,500 KRW); the fair value is what the company's own numbers justify (22,268 KRW). For VITZROCELL Co.Ltd the two are 1,768 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is VITZROCELL Co.Ltd worth?
The market values VITZROCELL Co.Ltd at about 1.1T KRW (market capitalisation, as of Nov 6, 2026). Per share that is 20,500 KRW; our models calculate a fair value of 22,268 KRW per share.
What do the bullish and bearish scenarios say about 082920?
Our models span a range for VITZROCELL Co.Ltd: cautious scenario 14,768 KRW, base 22,268 KRW, optimistic 36,320 KRW per share (as of Nov 6, 2026, price 20,500 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How far is 082920 from its 52-week high?
VITZROCELL Co.Ltd trades at 20,500 KRW, about 68% below its 52-week high of 64,100 KRW and 63% above the low of 12,544 KRW (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 22,268 KRW is for.
Which stocks are comparable to VITZROCELL Co.Ltd?
From the same area (Industrials) we also value Sungho Electronics Corp, SPG Co, BHI Co, Tae Kwang Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is VITZROCELL Co.Ltd stock attractive at the current price?
The data as of Nov 6, 2026: price 20,500 KRW, calculated fair value 22,268 KRW (+9%), Quality Score 55/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 082920 calculated?
We run VITZROCELL Co.Ltd through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 22,268 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. VITZROCELL Co.Ltd currently trades 8% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of VITZROCELL Co.Ltd (082920)?
The closing price on Nov 6, 2026 was 20,500 KRW. Our model-based fair value is 22,268 KRW, about +9% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with VITZROCELL Co.Ltd right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. A fairly wide model range (14,768 KRW to 36,320 KRW) leaves room in how you read the outcome.
Key figures of VITZROCELL Co.Ltd
How large is the market capitalisation of VITZROCELL Co.Ltd (082920)?
The market capitalisation of VITZROCELL Co.Ltd is 1.1T KRW (≈ $784M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of VITZROCELL Co.Ltd (082920)?
The price-to-sales ratio of VITZROCELL Co.Ltd is 9.02 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of VITZROCELL Co.Ltd (082920)?
The dividend yield of VITZROCELL Co.Ltd is 1.2%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of VITZROCELL Co.Ltd (082920)?
The net margin of VITZROCELL Co.Ltd is 19.8% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of VITZROCELL Co.Ltd (082920)?
The return on equity (ROE) of VITZROCELL Co.Ltd is 1,997% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of VITZROCELL Co.Ltd (082920)?
On an EBIT basis the return on assets of VITZROCELL Co.Ltd is 14.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of VITZROCELL Co.Ltd (082920)?
The operating margin of VITZROCELL Co.Ltd is 16.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at VITZROCELL Co.Ltd (082920)?
Revenue at VITZROCELL Co.Ltd is growing +25.9% versus a year earlier (3y avg +19.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at VITZROCELL Co.Ltd (082920)?
Earnings per share at VITZROCELL Co.Ltd are growing +119% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does VITZROCELL Co.Ltd (082920) carry?
The net debt of VITZROCELL Co.Ltd is 372M KRW (fiscal year 2021, ≈ 0.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch VITZROCELL Co.Ltd in the live analysis
One click puts VITZROCELL Co.Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 6, 2026